With over 43 years of pharmaceutical industry experience, Tim is a founding officer and current Chairman/COO of Neva Analytics LLC. (Neva). This experience extends directly across several pharma organizations ranging from large global operations (American Home Products/Wyeth-Ayerst) and mid-size development programs (Amylin Pharmaceuticals), to early-stage/startup companies (FeRx Incorporated and RMC Pharmaceutical Solutions, Inc.) – as well as simultaneously serving in multiple contract senior management roles for global organizations since 2005 until his retirement as Principal Consultant at RMC in 2023. This uniquely diverse background, includes direct experience overseeing the entire GxP spectrum (i.e., GMP, GLP, GCP, GDP and GVP) of activities that support pre-clinical/clinical research, CMC/product development and commercialization of regulated drug and device products on a global basis. This background is not only an asset to Neva’s corporate development, but it allows Tim to serve as a key internal quality and operational advisor to the Neva operations team.
Board Of Directors
Timothy Joy
Co-Founder, Chairman & COO
Scott Rudge
Co-Founder & CEOSince co-founding RMC Pharmaceutical Solutions in May 2004, Scott has been involved in a wide variety of projects for small and large biotech/pharmaceutical companies. He has overseen and/or performed assay, equipment, sterilization, cleaning and process validation, formulation development, due diligence for a multimillion dollar investment, construction of a new GMP facility for tissue processing, and tech transfer for a major late stage biotechnology product. In his last position, Scott served as the Vice President of Operations at FeRx Incorporated, overseeing manufacturing, process and product development, analytical development, formulation, facility design, construction and operation, and intellectual property.